What you should know

  • Kennedy’s Disease refers to Spinal and Bulbar Muscular Atrophy (SBMA) and is a rare kind of inherited disease that affects the nerve cells in the human brain

  • The disease causes the muscles of the face and limbs to become weaker and waste away

  • Other major symptoms include enlargement of breasts, muscle cramps and spasms, hand tremors, impotence, and speech and swallowing difficulties

  • The symptoms can be managed, and the disease is not usually life-limiting, but there is no cure

  • Age of onset is usually between 35 and 40 years, and men are more commonly affected.

What is Kennedy’s Disease?

Kennedy’s Disease refers to Spinal and Bulbar Muscular Atrophy (SBMA) and is a rare inherited disease that affects neurons (nerve cells) in the brain.1

Kennedy’s Disease is named after William R. Kennedy, who reported seeing this disease in patients in 1968.1

It is estimated that around 1 to 2 per 100,000 people worldwide have Kennedy’s Disease, although the number may be higher due to difficulties with making a definitive diagnosis.1

The disease is characterised by the degeneration of lower motor neurons of the brainstem and spinal cord.2 This results in the muscles of the face and limbs becoming weaker and wasting away.3

The loss of muscle strength eventually leads to weakness throughout the body, making movement difficult, particularly in the legs and arms, and affecting speech and swallowing. Kennedy’s Disease more commonly affects men.

Other major symptoms of the disease include enlargement of breasts, muscle cramps and spasms, hand tremors, impotence, and speech and swallowing difficulties.4 The symptoms can be managed, but there is no cure.5

Age of onset is usually between 35 and 40 years.1 The disease generally progresses slowly6 and does not usually impact life expectancy.7

Genetic mutation and Kennedy’s Disease

A mutation in the androgen receptor gene (AR) causes the disease.8 The androgen receptor gene is located on the X chromosome9 and helps to control the activity of male sex hormones (androgens).

Why are men mostly affected?

Men who inherit the mutated androgen receptor gene develop the disease. The mutated gene is on the X chromosome, one of the two chromosomes that determine human sex. Men have X and Y chromosomes.10 

Women have two X chromosomes.10 Women who inherit the mutated gene also carry it on their X chromosome. The normal gene on the other X chromosome usually overrides the mutated gene, so it is rare for a woman to develop the disease. Women who have inherited the mutated gene are carriers of the disease.1 Each son of a woman who is a carrier has a 50% chance of inheriting the gene and developing the disease.1

Diagnosis

Kennedy’s Disease is rare and can be misdiagnosed, often being mistaken for motor neurone disease (MND) as it shares a lot of similar symptoms. A thorough medical review is required to make an accurate diagnosis and includes assessment of the patient’s family history, symptoms and rate of progression. Tests11 used to confirm a diagnosis of Kennedy’s Disease include:

  • Genetic tests using a blood sample that looks for the faulty gene

  • A blood test to check for elevated serum creatine kinase (CPK) as almost all patients with SBMA are found to have very high levels, and

  • Neurologist assessments for elevated CAG repeats (a segment of DNA).

Similarity and differences with MND

The main similarity between Kennedy’s Disease and MND is the symptoms they display. Both diseases cause muscle weakness and wasting. While the wasting of muscles can make Kennedy’s Disease easy to mistake for MND, there are a number of significant differences between the diseases.

The differences mainly stem from the age at which the diseases start, their genetic causes, their rates of occurrence, how fast they progress, their associated life expectancy, and which gender is more commonly affected.

How is Kennedy’s Disease managed?

Currently, there is no cure for Kennedy’s Disease. Treatment aims to reduce and manage the symptoms. A healthy lifestyle that includes a balanced diet, gentle and regular aerobic exercise, plenty of rest, and avoiding exhaustion plays a big part in daily management. Regular stretching can also help reduce muscle cramping.

Other interventions11 include:

  • medications to reduce muscle cramps and tremors

  • pain management

  • speech therapy

  • occupational therapy

  • physiotherapy

  • dietary advice

  • fall prevention

Where to get support

Talking with your General Practitioner (GP) is the best place to start if you have any suspicions that you may have Kennedy’s Disease. You will usually be referred to a neurologist for further review and testing.

If you are diagnosed with Kennedy’s Disease, call the MND Info Line on 1800 777 175 to connect with your local MND State organisation. MND Australia and the MND State organisations recognise and support people living with Kennedy’s disease, their families and carers

Female carriers of Kennedy's Disease can receive genetic and fertility specialist advice to help reduce the chance of passing on the disease. MND State organisations provide ongoing support through their advisors.

You can also find support from others affected by Kennedy’s Disease in the private Facebook group Kennedy's Disease Downunder.

Sources

Adapted from MND Victoria's information sheet: Kennedy's Disease

MND Australia consulted with a representative of the Australian Kennedy’s Disease community in the development of this resource.


1. Breza and Koutsis, 2019, ‘Kennedy's Disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease’, Journal of Neurology 266 (3): 565-573.

2. Hoo et al, 2015, ‘Androgen-modulating agents for spinal bulbar muscular atrophy/Kennedy’s Disease (Protocol)’, Cochrane Database of Systematic Reviews, Issue 12.

3. Liu et al, 2019, ‘Clinical manifestations and AR gene mutations in Kennedy's Disease’, Functional & Integrative Genomics, 19(3): 533-539.

4. Motor Neurone Disease Association, 2019, ‘Kennedy’s Disease: Information for people with or affected by Kennedy’s Disease’, Northampton, United Kingdom.

5. Orrell and Figlewicz, 2001, ‘Clinical Implications of the Genetics of ALS and Other Motor Neuron Diseases’, Neurology, 57(1):9-17.

6. Lu et al, 2017, ‘Kennedy's Disease 1234 scale: Preliminary design and test’, Journal of Clinical Neuroscience, 40:185-189.

7. Querin et al, 2018, ‘Biomarkers of Spinal and Bulbar Muscle Atrophy (SBMA): A Comprehensive Review’, Frontiers in Neurology, 9: 844.

8. Rosenbohm et al, 2018, ‘The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy’, Journal of Neurology, 265(5): 1026- 1036.

9. Finsterer et al, 2016, ‘Onset Manifestations of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)’, Journal of Molecular Neuroscience, 58(3):321-9.

10. Bakker, 2019, ‘The Sexual Differentiation of the Human Brain: Role of Sex Hormones Versus Sex Chromosomes’, Current Topics in Behavioral Neuroscience, 43:45-67.

11. Better Health Channel, ‘Kennedy’s Disease’, Accessed: 12 May 2020, https://www.betterhealth.vic.gov.au/health/ConditionsAndTreatments/kennedys-disease